Interventionist Societies

Sociedad Peruana de Hemodinámica e Intervencionismo Endovascular (SOPHIE)

solaci
solaci
583
0

Sociedad Peruana de Hemodinámica e Intervencionismo Endovascular (SOPHIE)

Previous article
SOLACI at ACC / AHA / SCAI recommendation guides
Next article
Eventos clínicos tardíos en pacientes diabéticos tratados con stents farmacológicos liberadores de sirolimus o everolimus: un análisis del registro DESIRE
solaci
solaci

More articles by this author

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

solaci - 0
Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

Sociedad Venezolana de Cardiología Intervencionista (SOVECI)

solaci - 0
Sociedad Venezolana de Cardiología Intervencionista (SOVECI)

Colegio Colombiano de Hemodinamia e Intervencionismo Cardiovascular (CCHICV)

solaci - 0
Colegio Colombiano de Hemodinamia e Intervencionismo Cardiovascular (CCHICV)

Sociedad de Cardiología Intervencionista de México (SOCIME)

solaci - 0
Sociedad de Cardiología Intervencionista de México (SOCIME)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Interventionist Societies

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)

Asociación Dominicana de Cardiólogos Intervencionistas (ASODCI)
solaci -
SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Dr. Juan Manuel Pérez - 0
Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 0
Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 0
Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...